- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
ARV-825 is a hetero-bifunctional PROteolysis TArgeting Chimera (PROTAC) containing a BRD4 binding group (OTX-015) on one end, a linker arm, and a cereblon (CRBN) ubiquitin E3 ligase binding group (Pomalidomide) on the other end, resulting in BRD4 ubiquitylation and degradation by the proteasome. In Burkitt’s lymphoma cells, ARV-825 was found to cause prolonged BRD4 downregulation, reduce c-Myc levels, block cell proliferation, and induce apoptosis with improved results compared to BRD4 inihbitors such as JQ1 and OTX015. It showed similar results.
Hetero-bifunctional compound with a BRD4 binding group and a ubiquitin E3 ligase binding group, resulting in BRD4 ubiquitylation and degradation.
| Quality Segment | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | −20°C |
| SMILES string | ClC1=CC=C(C2=N[C@@H](CC(NC3=CC=C(C=C3)OCCOCCOCCOCCNC4=C(C5=CC=C4)C(N(C5=O)C6C(NC(CC6)=O)=O)=O)=O)C7=NN=C(C)N7C8=C2C(C)=C(C)S8)C=C1 |
| InChI key | RWLOGRLTDKDANT-TYIYNAFKSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
¥ 2290.21
-
¥ 1866.29
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 238.17
-
询价
-
询价
-
¥ 1749.15
-
¥ 745.60
-
¥ 3896.11
-
¥ 1351.48
-
¥ 3662.39
-
询价
-
¥ 75435.65
-
¥ 65710.50
微信小程序
7X24小时在线咨询